Cargando…

Incidental Detection of Synchronous Medullary Thyroid Carcinoma with Bilateral Adrenal Pheochromocytoma on Iodine-123 Metaiodobenzylguanidine Scintigraphy, Leading to Diagnosis of Multiple Endocrine Neoplasia 2A

We report a case of a 29-year-old female with the family history of medullary thyroid carcinoma (MTC) presenting with hematuria and tachycardia, who was found to have bilateral adrenal masses on abdominal computed tomography and biochemical testing compatible with pheochromocytoma. Iodine-123 (I-123...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakhri, Asif Ali, Rodrigue, Paul David, Aladin, Mustafa, Hussain, Aun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436327/ https://www.ncbi.nlm.nih.gov/pubmed/28553188 http://dx.doi.org/10.4103/1450-1147.203074

Ejemplares similares

Complete remission of metastatic pheochromocytoma in (123)I-metaiodobenzylguanidine scintigraphy after a single session of (131)I-metaiodobenzylguanidine therapy: a case report
por: Sugino, Teruaki, et al.
Publicado: (2017)

A Case of (123)I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the RET Gene
por: Kubo, Haremaru, et al.
Publicado: (2022)

(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021)

Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington’s disease
por: Assante, Roberta, et al.
Publicado: (2020)

Uptake Index of (123)I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2017)

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

A Family with Von Hippel-Lindau Syndrome: The Findings of Indium-111 Somatostatin Receptor Scintigraphy, Iodine-123 Metaiodobenzylguanidine Scintigraphy and Single Photon Emission Computerized Tomography
por: Arıcan, Pelin, et al.
Publicado: (2017)

Integrated Imaging Characterization of Adrenal Adenoma: False-Positive Metaiodobenzylguanidine (MIBG) Findings of Adrenal Scintigraphy
por: Dell’Aversana, Serena, et al.
Publicado: (2017)

False-positive (123)I-metaiodobenzylguanidine scintigraphy in a patient with a gastrointestinal stromal tumor presenting as a left adrenal incidentaloma
por: Sugito, Erika, et al.
Publicado: (2023)

Cardiac (123)I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Parkin Gene Mutation
por: Kim, Young-Do, et al.
Publicado: (2010)

(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
por: Chung, Eun Joo, et al.
Publicado: (2015)

Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
por: Matsubara, Tomoyasu, et al.
Publicado: (2022)

Changes in cardiac sympathetic nerve activity on (123)I‐metaiodobenzylguanidine scintigraphy after MitraClip therapy
por: Fukuda, Keisuke, et al.
Publicado: (2021)

Two Cases of Decreased (123)I-Metaiodobenzylguanidine Lung Uptake in Metaiodobenzylguanidine Scintigraphy While Taking Selective Serotonin Reuptake Inhibitor/Serotonin Noradrenaline Reuptake Inhibitor
por: Adaniya, Shinobu, et al.
Publicado: (2021)

Validation of a Five-Year Prognostic Model Using (123)I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure
por: Ishibashi, Yohei, et al.
Publicado: (2023)

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
por: Bax, Jeroen J., et al.
Publicado: (2008)

The Potential Role of Iodine-123 Metaiodobenzylguanidine Imaging for Identifying Sustained Ventricular Tachycardia in Patients with Cardiomyopathy
por: Klein, Thomas, et al.
Publicado: (2013)

Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation
por: Teresińska, Anna
Publicado: (2018)

False Positive Radioiodinated Metaiodobenzylguanidine ((123)I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor
por: Jung, Hee Soo, et al.
Publicado: (2015)

Acute coronary syndrome: a rare case of multiple endocrine neoplasia syndromes with pheochromocytoma and medullary thyroid carcinoma
por: Maloberti, Alessadro, et al.
Publicado: (2015)

Pheochromocytoma arising from an ectopic adrenal tissue in multiple endocrine neoplasia type 2A
por: Ohsugi, Haruyuki, et al.
Publicado: (2019)

Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses
por: Lamotte, Guillaume, et al.
Publicado: (2015)

Recurrent Pheochromocytoma, as Component of Multiple Endocrine Neoplasia
por: Dominguez, Hydelene Beray, et al.
Publicado: (2021)

The potential for early diagnosis of pulmonary arterial hypertension using lung iodine-123-metaiodobenzylguanidine ((123)I-MIBG) uptake: A case report
por: Higo, Kenjuro, et al.
Publicado: (2020)

Adrenal Pheochromocytoma Incidentally Discovered in a Patient With Parkinsonism
por: Petramala, Luigi, et al.
Publicado: (2015)

A case of normotensive incidentally discovered adrenal pheochromocytoma
por: Ohara, Nobumasa, et al.
Publicado: (2018)

Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of (123)I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability
por: Scholte, Arthur J. H. A., et al.
Publicado: (2010)

OR29-3 High-specific-activity Iodine 131 Metaiodobenzylguanidine for the Treatment of Advanced Pheochromocytoma and Paraganglioma: A Real-world Study
por: Al-ward, Ruaa
Publicado: (2022)

Multiple endocrine neoplasia similar to human subtype 2A in a dog: Medullary thyroid carcinoma, bilateral pheochromocytoma and parathyroid adenoma
por: Arias, E.A. Soler, et al.
Publicado: (2016)

Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma
por: Falhammar, Henrik, et al.
Publicado: (2019)

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine
por: Jimenez, Camilo, et al.
Publicado: (2019)

Vaginal delivery in a patient with pheochromocytoma, medullary thyroid cancer, and primary hyperparathyroidism (multiple endocrine neoplasia type 2A, Sipple's syndrome)
por: Muzannara, Muhammad Anas, et al.
Publicado: (2014)

Late gadolinium enhancement on cardiac magnetic resonance combined with (123)I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy
por: Chimura, Misato, et al.
Publicado: (2019)

Adrenal Medullary Hyperplasia Is a Precursor Lesion for Pheochromocytoma in MEN2 Syndrome()()
por: Korpershoek, Esther, et al.
Publicado: (2014)

Multiple Endocrine Neoplasia 2a Presenting with Pheochromocytoma and Pituitary Macroadenoma
por: Heinlen, Jonathan E., et al.
Publicado: (2011)

Calvarial metastasis from malignant pheochromocytoma associated with multiple endocrine neoplasia
por: Hernandez, Mary Angeline Luz Ubias, et al.
Publicado: (2022)

I -123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients
por: Zhou, Weihua, et al.
Publicado: (2013)

Thyroid function after diagnostic (123)I-metaiodobenzylguanidine in children with neuroblastic tumors
por: Clement, Sarah C., et al.
Publicado: (2022)

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009)

Multiple endocrine neoplasia type 1 and adrenal Cushing's
por: Vithian, Karunakaran, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kiqo8ptavo0j5sfmdm4mij7hnq